Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2006-10-25 11:03:23 UTC |
---|
Update Date | 2022-03-07 02:49:25 UTC |
---|
HMDB ID | HMDB0005083 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | 8-Isoprostaglandin F2a |
---|
Description | 8-Isoprostaglandin F2a is an isoprostane and a potent renal vasoconstrictor. Isoprostanes are prostaglandin-like compounds that are produced in vivo in humans by a noncyclooxygenase mechanism involving free radical-catalyzed peroxidation of arachidonic acid. The formation of these prostanoids proceeds through bicyclic endoperoxide intermediates that are then reduced to form ring isoprostanes. Of considerable interest is that, in contradistinction to cyclooxygenase-derived prostaglandins, isoprostanes have been shown to be initially formed in situ, esterified to phospholipids, and subsequently released preformed, presumably by phospholipases. The fact that prostanoids are produced in vivo by a noncyclooxygenase mechanism is of considerable interest from a biochemical perspective. However, this may also be associated with biological ramifications since it has been shown that these compounds are capable of exerting potent biological activity. (PMID: 7825845 , 17012140 ). Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. 8-iso-prostaglandin F2A is a biomarker for the consumption of offal meat. |
---|
Structure | CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@H]1C\C=C/CCCC(O)=O InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-19,21-23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16-,17+,18-,19+/m0/s1 |
---|
Synonyms | Value | Source |
---|
8-Epi-PGF2alpha | ChEBI | 8-Epiprostaglandin F2alpha | ChEBI | 8-Iso-PGF2a | ChEBI | 8-Iso-PGF2alpha | ChEBI | 8-Iso-PGF2alpha-III | ChEBI | 8-IsoP | ChEBI | 8-Isoprostaglandin F2alpha | ChEBI | 8-Isoprostane | ChEBI | 9,11,15-Trihydroxy-prosta-5,13-dien-1-Oic acid | ChEBI | 8-Epi-prostaglandin F2alpha | Kegg | 8-Epi-PGF2a | Generator | 8-Epi-PGF2α | Generator | 8-Epiprostaglandin F2a | Generator | 8-Epiprostaglandin F2α | Generator | 8-Iso-PGF2α | Generator | 8-Iso-PGF2a-III | Generator | 8-Iso-PGF2α-III | Generator | 8-Isoprostaglandin F2α | Generator | 9,11,15-Trihydroxy-prosta-5,13-dien-1-Oate | Generator | 8-Epi-prostaglandin F2a | Generator | 8-Epi-prostaglandin F2α | Generator | (5Z,13E,15S)-9alpha,11alpha,15-Trihydroxy-8beta-prosta-5,13-dien-1-Oate | HMDB | (5Z,13E,15S)-9alpha,11alpha,15-Trihydroxy-8beta-prosta-5,13-dien-1-Oic acid | HMDB | 8-Epi PGF-2alpha | HMDB | 9,11,15-Trihydroxy prosta-5,13-dien-1-Oate | HMDB | 9,11,15-Trihydroxy prosta-5,13-dien-1-Oic acid | HMDB | 9S,11R,15S-Trihydroxy-5Z,13E-prostadienoate | HMDB | 9S,11R,15S-Trihydroxy-5Z,13E-prostadienoic acid | HMDB | 9S,11R,15S-Trihydroxy-5Z,13E-prostadienoic acid-cyclo[8S,12R] | HMDB | 15-F(2t)-IsoP | HMDB | 15-F(2t)-Isoprostane | HMDB | 8-F(2t)-Isoprostane | HMDB | 8-Epi-PGF2 alpha | HMDB | 8-Iso-PGF(2alpha) | HMDB | Isoprostaglandin F2alpha type-III | HMDB | 15-F2t-IsoP | HMDB | 15-F2t-Isoprostane | HMDB | 8-Isoprostaglandin F2a | Generator |
|
---|
Chemical Formula | C20H34O5 |
---|
Average Molecular Weight | 354.481 |
---|
Monoisotopic Molecular Weight | 354.240624198 |
---|
IUPAC Name | (5Z)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]cyclopentyl]hept-5-enoic acid |
---|
Traditional Name | 8-isoprostane |
---|
CAS Registry Number | 27415-26-5 |
---|
SMILES | CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)C[C@H](O)[C@H]1C\C=C/CCCC(O)=O |
---|
InChI Identifier | InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-19,21-23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16-,17+,18-,19+/m0/s1 |
---|
InChI Key | PXGPLTODNUVGFL-NAPLMKITSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as prostaglandins and related compounds. These are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Fatty Acyls |
---|
Sub Class | Eicosanoids |
---|
Direct Parent | Prostaglandins and related compounds |
---|
Alternative Parents | |
---|
Substituents | - Prostaglandin skeleton
- Long-chain fatty acid
- Hydroxy fatty acid
- Cyclopentanol
- Fatty acid
- Unsaturated fatty acid
- Cyclic alcohol
- Secondary alcohol
- Carboxylic acid derivative
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Organic oxide
- Organic oxygen compound
- Alcohol
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Aliphatic homomonocyclic compound
|
---|
Molecular Framework | Aliphatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | 2.183 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times UnderivatizedChromatographic Method | Retention Time | Reference |
---|
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 5.99 minutes | 32390414 | Predicted by Siyang on May 30, 2022 | 12.6993 minutes | 33406817 | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.76 minutes | 32390414 | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 65.0 seconds | 40023050 | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2585.7 seconds | 40023050 | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 196.2 seconds | 40023050 | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 169.5 seconds | 40023050 | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 178.3 seconds | 40023050 | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 206.4 seconds | 40023050 | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 552.1 seconds | 40023050 | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 452.8 seconds | 40023050 | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 161.6 seconds | 40023050 | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1144.0 seconds | 40023050 | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 494.6 seconds | 40023050 | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1368.0 seconds | 40023050 | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 335.2 seconds | 40023050 | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 372.2 seconds | 40023050 | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 368.5 seconds | 40023050 | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 167.6 seconds | 40023050 | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 11.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
8-Isoprostaglandin F2a,1TMS,isomer #1 | CCCCC[C@@H](/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O)O[Si](C)(C)C | 2883.7 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,1TMS,isomer #2 | CCCCC[C@H](O)/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O[Si](C)(C)C | 2784.6 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,1TMS,isomer #3 | CCCCC[C@H](O)/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O)[C@@H](O[Si](C)(C)C)C[C@H]1O | 2765.8 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,1TMS,isomer #4 | CCCCC[C@H](O)/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O[Si](C)(C)C)[C@@H](O)C[C@H]1O | 2816.1 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,2TMS,isomer #1 | CCCCC[C@@H](/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O[Si](C)(C)C)[C@@H](O)C[C@H]1O)O[Si](C)(C)C | 2827.9 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,2TMS,isomer #2 | CCCCC[C@@H](/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O)[C@@H](O[Si](C)(C)C)C[C@H]1O)O[Si](C)(C)C | 2746.0 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,2TMS,isomer #3 | CCCCC[C@@H](/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O[Si](C)(C)C)O[Si](C)(C)C | 2755.7 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,2TMS,isomer #4 | CCCCC[C@H](O)/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O[Si](C)(C)C)[C@@H](O)C[C@H]1O[Si](C)(C)C | 2762.8 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,2TMS,isomer #5 | CCCCC[C@H](O)/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O)[C@@H](O[Si](C)(C)C)C[C@H]1O[Si](C)(C)C | 2750.7 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,2TMS,isomer #6 | CCCCC[C@H](O)/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)C[C@H]1O | 2742.2 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,3TMS,isomer #1 | CCCCC[C@@H](/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)C[C@H]1O)O[Si](C)(C)C | 2730.6 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,3TMS,isomer #2 | CCCCC[C@@H](/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O[Si](C)(C)C)[C@@H](O)C[C@H]1O[Si](C)(C)C)O[Si](C)(C)C | 2744.9 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,3TMS,isomer #3 | CCCCC[C@@H](/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O)[C@@H](O[Si](C)(C)C)C[C@H]1O[Si](C)(C)C)O[Si](C)(C)C | 2718.1 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,3TMS,isomer #4 | CCCCC[C@H](O)/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)C[C@H]1O[Si](C)(C)C | 2713.7 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,4TMS,isomer #1 | CCCCC[C@@H](/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)C[C@H]1O[Si](C)(C)C)O[Si](C)(C)C | 2746.0 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,1TBDMS,isomer #1 | CCCCC[C@@H](/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O)O[Si](C)(C)C(C)(C)C | 3139.4 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,1TBDMS,isomer #2 | CCCCC[C@H](O)/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O[Si](C)(C)C(C)(C)C | 2997.0 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,1TBDMS,isomer #3 | CCCCC[C@H](O)/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)C[C@H]1O | 2980.6 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,1TBDMS,isomer #4 | CCCCC[C@H](O)/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)C[C@H]1O | 3080.5 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,2TBDMS,isomer #1 | CCCCC[C@@H](/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)C[C@H]1O)O[Si](C)(C)C(C)(C)C | 3363.9 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,2TBDMS,isomer #2 | CCCCC[C@@H](/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)C[C@H]1O)O[Si](C)(C)C(C)(C)C | 3232.7 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,2TBDMS,isomer #3 | CCCCC[C@@H](/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3245.1 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,2TBDMS,isomer #4 | CCCCC[C@H](O)/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)C[C@H]1O[Si](C)(C)C(C)(C)C | 3243.4 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,2TBDMS,isomer #5 | CCCCC[C@H](O)/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)C[C@H]1O[Si](C)(C)C(C)(C)C | 3197.2 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,2TBDMS,isomer #6 | CCCCC[C@H](O)/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)C[C@H]1O | 3227.3 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,3TBDMS,isomer #1 | CCCCC[C@@H](/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)C[C@H]1O)O[Si](C)(C)C(C)(C)C | 3479.2 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,3TBDMS,isomer #2 | CCCCC[C@@H](/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)C[C@H]1O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3490.6 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,3TBDMS,isomer #3 | CCCCC[C@@H](/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)C[C@H]1O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3429.7 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,3TBDMS,isomer #4 | CCCCC[C@H](O)/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)C[C@H]1O[Si](C)(C)C(C)(C)C | 3432.6 | Semi standard non polar | 33892256 | 8-Isoprostaglandin F2a,4TBDMS,isomer #1 | CCCCC[C@@H](/C=C/[C@@H]1[C@H](C/C=C\CCCC(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)C[C@H]1O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3625.0 | Semi standard non polar | 33892256 |
|
---|